Personalized prediction for a 44 year old man who takes Nature-Throid, Prilosec, Methylprednisolone (an AI-powered real world drug study)

Summary:

This is a personalized prediction of potential side effects and undetected conditions for up to one year, if you would have adverse effects. The study is created by eHealthMe based on data from the FDA.

What are the drugs?

Nature-throid has active ingredients of thyroid hormone. It is often used in hypothyroidism. eHealthMe is studying from 122 Nature-throid users. Check the latest studies of Nature-throid.
Prilosec has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 175,278 Prilosec users. Check the latest studies of Prilosec.
Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,641 Methylprednisolone users. Check the latest studies of Methylprednisolone.

What are the conditions?

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development) is found to be associated with 1,625 drugs and 2,555 conditions by eHealthMe. Check the latest studies of Hypothyroidism.
Gerd (gastro-oesophageal reflux disease) is found to be associated with 3,426 drugs and 3,413 conditions by eHealthMe. Check the latest studies of Gerd.
Ear infection is found to be associated with 1,949 drugs and 1,816 conditions by eHealthMe. Check the latest studies of Ear infection.

What are the symtoms?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,532 drugs and 1,660 conditions by eHealthMe. Check the latest studies of Psoriasis.

Potential side effects:

Acute kidney failure

7.47% for males aged 44 (±5) who have ear infection and gerd
6.89% for males aged 44 (±5) who have hypothyroidism and gerd

Chronic kidney disease

12.56% for males aged 44 (±5) who have ear infection and gerd
11.44% for males aged 44 (±5) who have hypothyroidism and gerd

Colon cancer

5.79% for males aged 44 (±5) who have ear infection and gerd
5.25% for males aged 44 (±5) who have hypothyroidism and gerd

Depression

10.53% for males aged 44 (±5) who have ear infection

Dermatitis bullous

5.92% for males aged 44 (±5) who have ear infection

Dizziness

5.54% for males aged 44 (±5) who have ear infection and hypothyroidism

Drug ineffective

5.3% for males aged 44 (±5) who take nature-throid
5.3% for males aged 44 (±5) who take prilosec
5.3% for males aged 44 (±5) who take methylprednisolone

Dyspnea

6.58% for males aged 44 (±5) who have ear infection

Encephalitis

7.24% for males aged 44 (±5) who have ear infection

Erythema multiforme

7.24% for males aged 44 (±5) who have ear infection

Fatigue

7.39% for males aged 44 (±5) who have ear infection and hypothyroidism

Headache

6.16% for males aged 44 (±5) who have ear infection and hypothyroidism

Joint pain

5.26% for males aged 44 (±5) who have ear infection

Lichenoid keratosis

5.92% for males aged 44 (±5) who have ear infection

Nausea

6.58% for males aged 44 (±5) who have ear infection

Nausea and vomiting

5.92% for males aged 44 (±5) who have ear infection

Oesophageal carcinoma

5.44% for males aged 44 (±5) who have ear infection and gerd

Otitis

5.92% for males aged 44 (±5) who have ear infection

Pain

5.26% for males aged 44 (±5) who have ear infection

Prostate cancer

7.25% for males aged 44 (±5) who have ear infection and gerd
6.58% for males aged 44 (±5) who have hypothyroidism and gerd

Psoriasis

100.0% for males aged 44 (±5) who take nature-throid and prilosec and have psoriasis
100.0% for males aged 44 (±5) who take nature-throid and methylprednisolone and have psoriasis
100.0% for males aged 44 (±5) who take prilosec and methylprednisolone and have psoriasis
100.0% for males aged 44 (±5) who have psoriasis with ear infection and gerd
100.0% for males aged 44 (±5) who have psoriasis with hypothyroidism and gerd

Rashes

5.26% for males aged 44 (±5) who have ear infection

Renal cell carcinoma

7.36% for males aged 44 (±5) who have ear infection and gerd
6.69% for males aged 44 (±5) who have hypothyroidism and gerd

Subileus

7.89% for males aged 44 (±5) who have ear infection

Tendonitis

5.92% for males aged 44 (±5) who have ear infection

Potential co-existing conditions:

Abdominal discomfort

11.99% for males aged 44 (±5) who have ear infection and gerd
10.89% for males aged 44 (±5) who have hypothyroidism and gerd

Childhood psychosis

7.89% for males aged 44 (±5) who have ear infection

Crohn's disease

10.2% for males aged 44 (±5) who have psoriasis with ear infection and gerd
8.93% for males aged 44 (±5) who have psoriasis with hypothyroidism and gerd

Depression

12.01% for males aged 44 (±5) who have ear infection and hypothyroidism
6.64% for males aged 44 (±5) who have ear infection and gerd

Diabetes

7.33% for males aged 44 (±5) who have ear infection and hypothyroidism

Dyslipidaemia

7.24% for males aged 44 (±5) who have ear infection

High blood cholesterol

9.3% for males aged 44 (±5) who have ear infection and hypothyroidism

High blood pressure

23.89% for males aged 44 (±5) who have ear infection and hypothyroidism

Hyperchlorhydria

5.76% for males aged 44 (±5) who have ear infection and gerd
5.25% for males aged 44 (±5) who have hypothyroidism and gerd

Hypersensitivity

10.2% for males aged 44 (±5) who have psoriasis with ear infection and gerd
8.93% for males aged 44 (±5) who have psoriasis with hypothyroidism and gerd

Indigestion

38.98% for males aged 44 (±5) who have ear infection and gerd
35.58% for males aged 44 (±5) who have hypothyroidism and gerd

Insomnia

10.2% for males aged 44 (±5) who have psoriasis with ear infection and gerd
8.93% for males aged 44 (±5) who have psoriasis with hypothyroidism and gerd
5.05% for males aged 44 (±5) who have ear infection and hypothyroidism

Otitis

9.36% for males aged 44 (±5) who have ear infection and hypothyroidism

Pain

10.68% for males aged 44 (±5) who have ear infection and gerd
10.68% for males aged 44 (±5) who have hypothyroidism and gerd
10.22% for males aged 44 (±5) who have ear infection and hypothyroidism

Psoriasis

76.79% for males aged 44 (±5) who have psoriasis with hypothyroidism and gerd
75.51% for males aged 44 (±5) who have psoriasis with ear infection and gerd
72.27% for males aged 44 (±5) who take nature-throid and prilosec and have psoriasis
72.27% for males aged 44 (±5) who take nature-throid and methylprednisolone and have psoriasis
72.27% for males aged 44 (±5) who take prilosec and methylprednisolone and have psoriasis

Psoriatic arthropathy

21.71% for males aged 44 (±5) who take nature-throid and prilosec and have psoriasis
21.71% for males aged 44 (±5) who take nature-throid and methylprednisolone and have psoriasis
21.71% for males aged 44 (±5) who take prilosec and methylprednisolone and have psoriasis
19.64% for males aged 44 (±5) who have psoriasis with hypothyroidism and gerd
18.37% for males aged 44 (±5) who have psoriasis with ear infection and gerd

Schizophrenia

5.16% for males aged 44 (±5) who have hypothyroidism

Stress and anxiety

7.94% for males aged 44 (±5) who have ear infection and hypothyroidism
5.08% for males aged 44 (±5) who have hypothyroidism and gerd

Type 2 diabetes

7.24% for males aged 44 (±5) who have ear infection

Vitamin supplementation

8.93% for males aged 44 (±5) who have psoriasis with hypothyroidism and gerd

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used, and more. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

Related publications that referenced our studies

Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.